Contact a Representative About TECENTRIQ in Combination
With COTELLIC® (cobimetinib) and ZELBORAF®
(vemurafenib)
Please remember: this feature is intended for US healthcare professionals only.
Please complete the form below if you would like a Genentech representative to contact you regarding further information about TECENTRIQ (atezolizumab) in combination with COTELLIC (cobimetinib) and ZELBORAF (vemurafenib). You should receive a response within 2 business days.
Your contact information will only be used for a representative to respond to your information request. It will not be used for any other purpose unless you register for Genentech updates by checking the box below.
Thank you for contacting us about TECENTRIQ
Your request has been submitted.
One of our Genentech representatives will contact you directly within 2 business days.
Your contact information will not be used for any other purpose than for the representative to respond to your information request.